Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Buy
51
PROK Quote, Financials, Valuation and Earnings
Last price:
$3.15
Seasonality move
:
-23.87%
Day range:
$3.52 - $4.05
52-week range:
$0.46 - $7.13
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
--
Volume:
7.5M
Avg. volume:
25.3M
1-year change:
53.04%
Market cap:
$456M
Revenue:
$76K
EPS (TTM):
-$0.60
Earnings Data
Next earnings date for PROK
Aug 08
2025
Most recent earnings per share
-$0.13
Beat by $0.02
(May 12/2025)
Consensus Estimate
-$0.15
(May 12/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
PROK Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 09/30/2025 | Q3 | -- | -- | -- | -$0.14 | -- |
| 08/08/2025 | Q2 | -- | -- | -- | -$0.14 | -- |
| 05/12/2025 | Q1 | -- | $230K | -$0.13 | -$0.15 | $0.02 |
| 03/17/2025 | Q4 | -- | $76K | -$0.17 | -$0.15 | -$0.02 |
| 11/12/2024 | Q3 | -- | -- | -$0.14 | -$0.22 | $0.08 |
| 08/09/2024 | Q2 | -- | -- | -$0.16 | -$0.18 | $0.02 |
| 05/10/2024 | Q1 | -- | -- | -$0.16 | -$0.18 | $0.02 |
| 03/21/2024 | Q4 | -- | -- | -$0.09 | -$0.18 | $0.09 |
| 11/14/2023 | Q3 | -- | -- | -$0.18 | -$0.14 | -$0.04 |
| 08/10/2023 | Q2 | -- | -- | -$0.14 | -$0.41 | $0.27 |
| 05/11/2023 | Q1 | -- | -- | -$0.16 | -- | -- |
| 03/28/2023 | Q4 | -- | -- | -$0.10 | -- | -- |
| 11/14/2022 | Q3 | -- | -- | -$0.13 | -- | -- |
| 08/11/2022 | Q2 | -- | -- | -$0.36 | -- | -- |
| 03/31/2022 | Q1 | -- | -- | -$0.36 | -- | -- |
| 12/31/2021 | Q4 | -- | -- | -$0.07 | -- | -- |
| 09/30/2021 | Q3 | -- | -- | -$0.09 | -- | -- |
| 06/30/2021 | Q2 | -- | -- | -$0.07 | -- | -- |
| 03/31/2021 | Q1 | -- | -- | -$0.06 | -- | -- |
ProKidney Earnings Questions
-
How Much did ProKidney Generate in Revenue Last Quarter?
ProKidney reported $230K worth of top line sales in its most recent quarter.
-
Did ProKidney Beat Earnings Last Quarter?
ProKidney announced earnings per share of -$0.13 which represents a beat of analyst forecast a -$0.15 per share.
-
Is ProKidney Profitable?
ProKidney reported -- that represents -- per share over the last quarter.
-
What is the Analyst Consensus for ProKidney EPS Next Year?
ProKidney's earnings are forecast to decrease from -$0.62 per share to -$0.59 per share next year representing a decrease of -9.74%.
-
When is ProKidney's Earnings Date?
ProKidney's next earnings date is August 8, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
71
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 59x
Buy
51
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
80
SOC alert for Jul 18
Sable Offshore [SOC] is up 11.86% over the past day.
Buy
71
PGY alert for Jul 18
Pagaya Technologies [PGY] is up 5.56% over the past day.
Buy
68
MCRI alert for Jul 18
Monarch Casino & Resort [MCRI] is up 0.31% over the past day.
